LUM and neoplasm: Therefore, ongoing studies are now aimed at further deciphering the pathway involved, as well as to investigate a putative role for lumican in fostering tumor response to immunotherapeutic approaches such as immune checkpoint inhibitors anti-PD-1 and anti-CTLA-4.